Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,713-2,724 of 4,306
Drug study icon
CompletedNCT00772005

Armodafinil for schizophrenia

This study is completed in the United States. It is testing armodafinil for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Cephalon
Condition
Schizophrenia
Drug study icon
CompletedNCT01009060

GSK239512 for schizophrenia

This study is completed in the United States. It is testing GSK239512 for schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
GlaxoSmithKline
Condition
Schizophrenia
Drug study icon
CompletedNCT00905307

Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for schizophrenia

This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00535132

Study to Measure Drug Satisfaction of people with Schizophrenia After Switching From Risperidone to Paliperidone

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Cerritos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
United States, Argentina, Colombia, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
TerminatedNCT03793712

Study With Lu AF11167 for Negative Symptoms in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Burgas
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Bulgaria, Czechia, Estonia, ...
Sponsor
H. Lundbeck A/S
Condition
Schizophrenia
Other study type icon
CompletedNCT01698216

Switching From Consta® to Sustenna® in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Seoul
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
South Korea
Sponsor
Seoul National University Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT00044655

Switching Medication to Treat Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Schizophrenia
Drug study icon
CompletedNCT01207414

Switching to Iloperidone From Other Antipsychotics in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Novartis
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03067311

Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Carrboro
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 15 Years to 35 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.